Order Article Reprints

Castillo RL, Farías J, Sandoval C, González-Candia A, Figueroa E, Quezada M, Cruz G, Llanos P, Jorquera G, Kostin S, et al. Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection? Antioxidants. 2024; 13(11):1388. https://doi.org/10.3390/antiox13111388

Castillo, Rodrigo L., Jorge Farías, Cristian Sandoval, Alejandro González-Candia, Esteban Figueroa, Mauricio Quezada, Gonzalo Cruz, Paola Llanos, Gonzalo Jorquera, Sawa Kostin, and et al. 2024. "Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection?" Antioxidants 13, no. 11: 1388. https://doi.org/10.3390/antiox13111388

Castillo, R. L., Farías, J., Sandoval, C., González-Candia, A., Figueroa, E., Quezada, M., Cruz, G., Llanos, P., Jorquera, G., Kostin, S., & Carrasco, R. (2024). Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection? Antioxidants, 13(11), 1388. https://doi.org/10.3390/antiox13111388